# Phase II Clinical Trial of Intraoral Grafting of Human Tissue Engineered Oral Mucosa

> **NCT01834326** · PHASE2 · TERMINATED · sponsor: **Stephen E. Feinberg** · enrollment: 18 (actual)

## Conditions studied

- Disorder of Oral Mucous Membrane

## Interventions

- **BIOLOGICAL:** EVPOME (autogenous ex vivo produced oral mucosa equivalent)
- **BIOLOGICAL:** POM (Palatal oral mucosa)

## Key facts

- **NCT ID:** NCT01834326
- **Lead sponsor:** Stephen E. Feinberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** The funding period for the study ended. The study did not reach full enrollment.
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834326, "Phase II Clinical Trial of Intraoral Grafting of Human Tissue Engineered Oral Mucosa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01834326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*